Following fields are empty!

1
Search
2
Select
3
Submit
142
Journals
Go to Previous Page
Page 5 of 8
Go to Next Page

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

Journal of Labelled Compounds and Radiopharmaceuticals

ISSN: 0362-4803eISSN: 1099-1344
SIGAPS Level E
Publisher: Wiley
Visit Publisher homepageVisit journal homepage
BiochemistryChemistry(all)Analytical ChemistryOrganic ChemistrySpectroscopyRadiology Nuclear Medicine and imagingDrug Discovery

The Official Journal of the International Isotope Society The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research in labelled compound preparation and application. This includes areas such as analytical control, self radiolysis, quality control handling, storage, and tracer methods used in chemical, biochemical, biological, pharmacological, medical, genetic, agricultural and geochemical research. All radionuclides and enriched stable nuclides are included. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to the following fields: radionuclide production; cyclotron targetry; neutron irradiation methodology; precursor preparation and production; labelling synthesis (chemical, biochemical, radiation, isotope exchange, etc); automation of nuclide production, precursor, preparation and synthesis; analysis (methods, limitations, etc. for both radioactive and stable nuclides, including new detection techniques); radiopharmaceuticals; PET chemistry; quality control (an essential requirement for valid data and especially for radiopharmaceuticals); stability and storage problems; handling of Curie and multiCurie amounts of radioactivity; etc. JLCR Award for Young Scientists: The Journal of Labelled Compounds and Radiopharmaceuticals, in cooperation with the International Isotope Society Conferences and the International Conferences on Radiopharmaceutical Sciences, sponsor every year four Awards to early excellence in radiopharmaceutical research and isotope labelling.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Journal of Molecular Medicine

ISSN: 0946-2716eISSN: 1432-1440
SIGAPS Level B
Publisher: Springer
Visit Publisher homepageVisit journal homepage
Molecular MedicineMedicine(all)Genetics(clinical)Drug Discovery

J Mol Med publishes reports describing major advances in the understanding, prevention, diagnosis, and treatment of human disease through the application of molecular biology and gene technology, a research discipline that has become known as molecular medicine.  The journal publishes original papers and review articles of the highest quality pertinent to all aspects of human biology and pathophysiology. J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

Les auteurs correspondants des Hospices Civils de Lyon ont la possibilité de publier leurs articles de recherches en Open Access dans cette revue. Pour bénéficier de cette prise en charge, déclarez les "Hospices Civils de Lyon" dans votre affiliation principale et utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article.

L'éditeur précise les consignes suivantes à respecter lors de la soumission via sa plateforme:

  1. Utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article
  2. Vérifiez que les Hospices Civils de Lyon apparaissent bien dans la zone "Institution"
  3. Liez votre ORCID à votre compte
  4. Si possible, réalisez la soumission depuis un ordinateur relié au réseau des HCL

ATTENTION:

  • Si l'éditeur vous demande de sélectionner la licence applicable, privilégiez la licence CC-BY à toutes autres.
  • L'accord porte uniquement sur les types d'articles suivants: "Article original", "Article de synthèse".
  • Veuillez noter que les types d'articles suivants ne sont pas couverts par cet accord : "Communication brève" et "Formation continue".
  • Cet accord ne concerne pas les revues Nature et BioMed Central (BMC).
  • Les articles publiés en accès ouvert immédiat au titre de l’accord peuvent être déposés dans leur version finale éditeur dans une archive ouverte, par exemple dans HAL-HCL.
  • Dans le cas des articles sous abonnement, il est permis par la Loi République numérique de déposer dans une archive ouverte le manuscrit auteur accepté d’un article et de le diffuser avec un embargo de 6 mois (sciences dures) ou 12 mois (SHS).

Si vous rencontrez des difficultés ou si vous avez des questions, contactez la Documentation Centrale sur sa.documentationcentrale@chu-lyon.fr ou au 04-72-11-29-99 (31-29-99)